Overview

"E4/DRSP Endocrine Function, Metabolic Control and Hemostasis Study"

Status:
Completed
Trial end date:
2017-10-09
Target enrollment:
Participant gender:
Summary
The proposed study will provide an assessment of the effect of this combination on endocrine function, metabolic control and hemostasis during 6 treatment cycles. This will be compared to the effects of two reference COCs.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Estetra
Treatments:
Contraceptive Agents
Contraceptives, Oral
Contraceptives, Oral, Combined
Drospirenone
Ethinyl Estradiol
Hemostatics
Levonorgestrel